Latest post

The new Perspectives Magazine 2020 is here

The new issue of Oxurion Perspectives magazine is here. Read about last year's highlights and the ambitious times ahead.

back of the eye diseases, science community,

Arshad Khanani: “Initial data of phase 1 trial of THR-687 point to clinical efficacy”

Arshad Khanani, M.D., M.A. about the clinical phase 1 data of THR-687.